Research from University of Miami Provides New Data on Acute Myeloid Leukemia (Common Driver Mutations in AML: Biological Impact, Clinical Considerations, and Treatment Strategies).
Předmět: | |
---|---|
Zdroj: | Hematology Week; 9/9/2024, p1876-1876, 1p |
Abstrakt: | The article highlights a study from the University of Miami reviews common driver mutations in acute myeloid leukemia (AML) and their implications for treatment. Topics include the prevalence of mutations in NPM1 and FLT3, the development and clinical trials of targeted therapies, and the impact of less common mutations like IDH1/2 and TP53 on treatment strategies and prognosis. |
Databáze: | Complementary Index |
Externí odkaz: |